Insider · CIK 0001785406

FORD KATHLEEN

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001785406

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-29	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−3,668 sh	$10.75	−$39.4K	142,986
2026-09-28	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,906 sh	$10.50	−$72.5K	146,654
2026-05-19	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−2,257 sh	$9.08	−$20.5K	153,560
2026-01-27	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−1,813 sh	$8.46	−$15.3K	153,560
2026-01-02	KURAKura Oncology, Inc.A Award	Chief Operating Officer	AAward	+50K sh	—	—	155,373
2026-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+100K sh	—	—	100,000
2025-11-14	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,902 sh	$11.18	−$77.1K	105,373
2025-11-13	KURAKura Oncology, Inc.A Award	Chief Operating Officer	AAward	+48.9K sh	—	—	112,275
2025-09-29	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,892 sh	$8.94	−$61.6K	63,375
2025-09-27	KURAKura Oncology, Inc.A Award	Chief Operating Officer	AAward	−48.9K sh	—	—	70,267
2025-05-19	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−1,558 sh	$6.28	−$9,777.385	21,367
2025-01-28	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−1,817 sh	$7.87	−$14.3K	21,367
2025-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+185K sh	—	—	185,000
2024-11-18	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−526 sh	$16.03	−$8,433.726	23,184
2024-01-29	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−1,496 sh	$17.80	−$26.6K	21,602
2024-01-02	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+185K sh	—	—	185,000
2023-02-16	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+185K sh	—	—	185,000
2023-01-27	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−1,821 sh	$13.89	−$25.3K	21,214
2022-01-26	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+171K sh	—	—	171,000
2022-01-26	KURAKura Oncology, Inc.A Award	Chief Operating Officer	AAward	+21.9K sh	—	—	23,035
2021-03-15	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,250 sh	—	—	215,625
2021-03-15	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	$19.43	+$121K	6,250
2021-03-15	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,250 sh	$29.43	−$184K	0
2021-01-26	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+140K sh	—	—	140,000
2020-12-15	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−9,375 sh	—	—	221,875
2020-12-15	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−3,125 sh	$40.60	−$127K	0
2020-12-15	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,125 sh	$19.43	+$60.7K	3,125
2020-12-15	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,250 sh	$40.60	−$254K	0
2020-12-15	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	$19.43	+$121K	6,250
2020-11-10	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	$19.43	+$121K	6,250
2020-11-10	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,250 sh	$39.43	−$246K	0
2020-11-10	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,250 sh	—	—	231,250
2020-09-15	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,250 sh	$29.43	−$184K	0
2020-09-15	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	$19.43	+$121K	6,250
2020-09-15	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,250 sh	—	—	237,500
2020-09-14	KURAKura Oncology, Inc. · Option to purchase common stockM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,250 sh	—	—	243,750
2020-09-14	KURAKura Oncology, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,250 sh	$19.43	+$121K	6,250
2020-09-14	KURAKura Oncology, Inc.S Sale	Chief Operating Officer	SSale	−6,250 sh	$29.43	−$184K	0
2020-01-30	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+45.4K sh	—	—	45,393
2019-08-09	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Operating Officer	AAward	+250K sh	—	—	250,000

Recent filings

Accepted (ET)
Sep 294
FORD KATHLEEN0001193125-26-407938
SEC(opens sec.gov)
May 204
FORD KATHLEEN0001193125-26-232548
SEC(opens sec.gov)
Jan 274
FORD KATHLEEN0001193125-26-025304
SEC(opens sec.gov)
Jan 64
FORD KATHLEEN0001193125-26-004567
SEC(opens sec.gov)
Nov 144
FORD KATHLEEN0001193125-25-283560
SEC(opens sec.gov)
Sep 294
FORD KATHLEEN0001193125-25-223665
SEC(opens sec.gov)
May 194
FORD KATHLEEN0000950170-25-074659
SEC(opens sec.gov)
Jan 284
FORD KATHLEEN0000950170-25-010118
SEC(opens sec.gov)
Jan 64
FORD KATHLEEN0000950170-25-002049
SEC(opens sec.gov)
Nov 194
FORD KATHLEEN0000950170-24-128558
SEC(opens sec.gov)
Jan 314
FORD KATHLEEN0000950170-24-009494
SEC(opens sec.gov)
Jan 44
FORD KATHLEEN0000950170-24-001846
SEC(opens sec.gov)
Feb 214
FORD KATHLEEN0001209191-23-011285
SEC(opens sec.gov)
Jan 314
FORD KATHLEEN0001209191-23-005753
SEC(opens sec.gov)
Jan 284
FORD KATHLEEN0001209191-22-005380
SEC(opens sec.gov)

Companies

Kura Oncology, Inc.Chief Operating OfficerKURA

Address

C/O KURA ONCOLOGY, INC. 4930 DIRECTORS PLACE, SUITE 500

SAN DIEGO, CA, 92121